VLST-002

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVLST-002
Drug Alias NameAntiKine antibodies (VLST)Virulence factor mimics (VLST)VLST-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionChemokine receptors antagonists
TargetsChemokine receptors
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVLST Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVLST Corp
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A